Shionogi CEO Drug Deals: Pursues Expansion, U.S. Production
Shionogi & Co. Ltd. is reportedly pursuing multiple drug acquisition opportunities while considering expanding its U.S. manufacturing capacity to diversify production. The company has…
Shionogi & Co. Ltd. is reportedly pursuing multiple drug acquisition opportunities while considering expanding its U.S. manufacturing capacity to diversify production. The company has…
Eli Lilly and Novo Nordisk are expanding production capacity for obesity and weight-loss treatments to support anticipated growth as medical coverage broadens and demand…
CVC Capital Partners has made a full-takeover offer for Recordati, valuing the Italian drugmaker at €10.9 billion (about $12 billion), with the intention of…
Kissei Pharmaceutical Co., which markets Amgen Inc.'s Tavneos in Japan, has advised doctors to stop prescribing the drug to new patients amid reports of…
Global lenders are weighing multiple financing options for Sun Pharmaceutical Industries' proposed $12 billion acquisition of Organon & Co., with reports suggesting the possibility…